REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSuperdry Regulatory News (SDRY)

Share Price Information for Superdry (SDRY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.74
Bid: 6.66
Ask: 6.99
Change: -0.41 (-5.73%)
Spread: 0.33 (4.955%)
Open: 6.28
High: 7.01
Low: 6.25
Prev. Close: 7.15
SDRY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 2.8 Announcement

28 Mar 2024 16:37

RNS Number : 7874I
Julian Marc Dunkerton
28 March 2024
 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")

 

FOR IMMEDIATE RELEASE

 

28 March 2024

 

Statement Regarding Superdry plc

 

Following a period of engagement with the Transaction Committee (being the Company's Board of Directors excluding Julian Dunkerton) of Superdry plc ("Superdry" or the "Company"), Julian Dunkerton, Founder and Chief Executive Officer of Superdry, and the Transaction Committee have, together, concluded that a takeover offer from Julian Dunkerton for the Company is unlikely to deliver an outcome for shareholders, or stakeholders more broadly, that the Transaction Committee and Julian Dunkerton are confident can be executed in the context of the Company's ongoing work on its turnaround plan and material cost saving options.

However, Julian Dunkerton remains fully committed to the Company over the long-term and is in discussions with the Company in respect of alternative structures, including a possible equity raise fully underwritten by Julian Dunkerton, which would provide additional liquidity headroom for the Company's turnaround plan. It is expected that any equity raise would be at a very material discount to the current share price, require shareholder approval of a Rule 9 waiver (as referred in Note 1 of the Notes on Dispensations from Rule 9 of the Code) and be conditional on a de-listing of the Company. A further announcement will be made as appropriate. There can be no certainty that a transaction with Julian Dunkerton will be agreed.

This is a statement to which Rule 2.8 of the Code applies.

For the purposes of Note 2 on Rule 2.8 of the Code, Julian Dunkerton and any person(s) acting in concert with him reserve the right to make or participate in an offer for Superdry (and/or take any other actions which would otherwise be restricted under Rule 2.8 of the Code) within the next six months following the date of this announcement in the following circumstances:

 

(i) with the agreement of the Transaction Committee;

 

(ii) following the announcement of a firm intention to make an offer for Superdry by or on behalf of a third party;

 

(iii) following the announcement by Superdry of a Rule 9 waiver proposal (as described in Note 1 of the Notes on Dispensations from Rule 9 of the Takeover Code) (excluding a Rule 9 waiver proposal by Julian Dunkerton) or a reverse takeover (as defined in the Code); or

 

(iv) where the Takeover Panel has determined that there has been a material change of circumstances.

 

Enquiries:

N. M. Rothschild & Sons Limited (Financial Adviser to Julian Dunkerton)

John Byrne

Charles Fenwick

+44 (0)121 600 5252

Important notice related to Financial Adviser

N. M. Rothschild & Sons Limited ("Rothschild & Co"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for Julian Dunkerton and for no one else in connection with the subject matter of this announcement and will not be responsible to anyone other than Julian Dunkerton for providing the protections afforded to its clients or for providing advice in connection with the subject matter of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPEAKDPAFELEFA
Date   Source Headline
26th Feb 20212:00 pmRNSTotal Voting Rights
17th Feb 20212:04 pmRNSDirector/PDMR Shareholding
11th Feb 20217:00 amRNSDirectorate Change
2nd Feb 202110:02 amRNSHolding(s) in Company
29th Jan 202112:00 pmRNSTotal Voting Rights
25th Jan 20212:00 pmRNSHolding(s) in Company
19th Jan 20217:00 amRNSHalf-year Report
15th Jan 20219:10 amRNSDirector/PDMR Shareholding
31st Dec 20201:00 pmRNSTotal Voting Rights
16th Dec 20207:00 amRNSDirectorate Change
15th Dec 202012:44 pmRNSDirector/PDMR Shareholding
30th Nov 20202:00 pmRNSTotal Voting Rights
16th Nov 202011:01 amRNSDirector/PDMR Shareholding
11th Nov 20201:00 pmRNSHolding(s) in Company
5th Nov 20207:00 amRNSTrading Statement
2nd Nov 202010:00 amRNSDirector/PDMR Shareholding
2nd Nov 20207:00 amRNSStatement re Interim CFO
30th Oct 20203:00 pmRNSTotal Voting Rights
27th Oct 20203:00 pmRNSDirector/PDMR Shareholding
27th Oct 202012:07 pmRNSDirector/PDMR Shareholding
22nd Oct 20202:12 pmRNSResult of AGM
22nd Oct 20208:00 amRNSDirector/PDMR Shareholding
20th Oct 20202:53 pmRNSDirector/PDMR Shareholding
19th Oct 20209:23 amRNSDirector/PDMR Shareholding
19th Oct 20209:08 amRNSStatement re AGM resolution
16th Oct 20207:00 amRNSDirectorate Change
14th Oct 202011:00 amRNSDirector/PDMR Shareholding
7th Oct 20203:44 pmRNSHolding(s) in Company
30th Sep 20202:00 pmRNSTotal Voting Rights
29th Sep 20209:10 amRNSNotice of AGM
25th Sep 202011:35 amRNSDirector/PDMR Shareholding
25th Sep 202011:30 amRNSDirector/PDMR Shareholding
23rd Sep 202012:00 pmRNSDirector/PDMR Shareholding
23rd Sep 202011:00 amRNSBlock listing Interim Review
22nd Sep 20203:15 pmRNSDirector/PDMR Shareholding
22nd Sep 202012:00 pmRNSDirector/PDMR Shareholding
22nd Sep 202012:00 pmRNSDirector/PDMR Shareholding
21st Sep 202012:00 pmRNSHolding(s) in Company
21st Sep 20207:00 amRNSFinal Results
17th Sep 202012:26 pmRNSStatement re preliminary results
15th Sep 202010:55 amRNSDirector/PDMR Shareholding
28th Aug 20203:00 pmRNSTotal Voting Rights
25th Aug 202012:02 pmRNSPrice Monitoring Extension
14th Aug 202011:00 amRNSDirector/PDMR Shareholding
10th Aug 20207:00 amRNSStatement re : New financing facility and trading
31st Jul 202011:00 amRNSTotal Voting Rights
24th Jul 20204:41 pmRNSSecond Price Monitoring Extn
24th Jul 20204:36 pmRNSPrice Monitoring Extension
23rd Jul 20209:34 amRNSHolding(s) in Company
21st Jul 202011:38 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.